内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Ramasastry Saira, 董事. Officer active across 4 companies, notably Vir Biotechnology, Inc.. In total, 23 filings have been published. Split: 0 buy · 5 sells. Total volume traded: €642k. Activity tracked since 19 May 2021. The latest transaction was filed on 15 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ramasastry Saira
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
40,485 股Common StockSEC:0001547959-26-000008:0
2,000 股@ US$23.510.0006% mcap14.8% 占其流量Common StockSEC:0001547959-26-000007:0
2,000 股@ US$96.900.0024% mcap61.0% 占其流量Common StockSEC:0001547959-26-000007:1
2,000 股@ US$23.517.6% 占其流量Common StockSEC:0001547959-26-000006:0
2,000 股@ US$23.513.6% 占其流量Common StockSEC:0001547959-26-000005:0
2,000 股@ US$23.513.7% 占其流量Common StockSEC:0001547959-26-000002:0
5,000 股@ US$23.519.8% 占其流量Common StockSEC:0001547959-25-000008:0
2,000 股@ US$23.514.4% 占其流量Common StockSEC:0001547959-25-000007:0
17,000 股@ US$23.5138.6% 占其流量Common StockSEC:0001415889-25-024128:0
5,703 股@ US$46.202346.1% 占其流量Common StockSEC:0001415889-25-015570:0
8,000 股0Common StockSEC:0001628280-25-028898:0
5,703 股Common StockSEC:0001415889-25-015306:0
10,000 股@ US$13.1877100.0% 占其流量Common StockSEC:0001415889-24-017877:0
4,000 股@ US$10.947310.3% 占其流量Common StockSEC:0001628280-24-027760:0
5,000 股@ US$14.12100.0% 占其流量Common StockSEC:0001415889-24-016064:0
8,000 股0Common StockSEC:0001628280-24-026215:0
3,500 股@ US$25.6721.0% 占其流量Common StockSEC:0001209191-23-033550:0
6,027 股0Common StockSEC:0001209191-23-031848:0
5,000 股@ US$12.7616.0% 占其流量Common StockSEC:0001209191-22-042039:0
6,405 股0Common StockSEC:0001209191-22-031948:0
12,500 股0Common StockSEC:0001209191-22-014153:0
3,374 股0Common StockSEC:0001209191-21-035715:0
10,000 股@ US$12.7624.0% 占其流量Common StockSEC:0001209191-21-034668:0
About Ramasastry Saira
Ramasastry Saira is Administrateur and has 23 filings in total. Across the 23 sampled filings, the period runs from 2021-05-20 to 2026-04-23, with €0 of buys and €641604 of sells, mainly in Mirum Pharmaceuticals, Inc., Vir Biotechnology, Inc., Day One Biopharmaceuticals, Inc. and Sangamo Therapeutics, INC.